butylscopolammonium bromide has been researched along with Cancer of Liver in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, S; Li, S; Peng, X; Wang, P; Zhang, G | 1 |
Kuroki, S; Kuroki, Y; Moriyama, N; Murakami, K; Nasu, K; Nawano, S | 1 |
Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y | 1 |
Kazama, T; Kuroki, Y; Nakajima, H; Nasu, K; Sekiguchi, R | 1 |
1 trial(s) available for butylscopolammonium bromide and Cancer of Liver
Article | Year |
---|---|
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.
Topics: Butylscopolammonium Bromide; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Obstruction; Liver Neoplasms; Middle Aged; Neoplasm Staging; Octreotide; Ovarian Neoplasms; Parasympatholytics; Peritoneal Neoplasms; Pleural Neoplasms; Prognosis; Prospective Studies; Severity of Illness Index | 2015 |
3 other study(ies) available for butylscopolammonium bromide and Cancer of Liver
Article | Year |
---|---|
Optimization of Gd-DTPA-enhanced balanced turbo field echo sequence in abdominal imaging: clinical application.
Topics: Blood Flow Velocity; Butylscopolammonium Bromide; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Gallbladder Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Pancreatic Neoplasms | 2004 |
Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Drug Combinations; Drug Stability; Drug Storage; Female; Haloperidol; Humans; Injections, Subcutaneous; Laryngeal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Morphine; Muscarinic Antagonists; Palliative Care; Retrospective Studies; Time Factors | 2006 |
Measurement of the apparent diffusion coefficient in the liver: is it a reliable index for hepatic disease diagnosis?
Topics: Adult; Aged; Butylscopolammonium Bromide; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Heart Rate; Hemangioma; Humans; Image Processing, Computer-Assisted; Japan; Liver Neoplasms; Male; Middle Aged; Muscarinic Antagonists; Neoplasm Staging; Reproducibility of Results; Sensitivity and Specificity | 2006 |